Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 83, Issue 3, 2010, Pages 131-136

  Sethom, M M ^a   Fares, S ^a   Bouaziz, N ^b   Melki, W ^b   Jemaa, R ^a   Feki, M ^a   Hechmi, Z ^b   Kaabachi, N ^a  

^a LA RABTA HOSPITAL   (Tunisia)

^b RAZI HOSPITAL   (Tunisia)

Author keywords

Antipsychotics agents; Arachidonic acid; Docosahexaenoic acid; Polyunsaturated fatty acids; Schizophrenia

Indexed keywords

ARACHIDONIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; DOCOSAHEXAENOIC ACID; HALOPERIDOL; MONOUNSATURATED FATTY ACID; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHENOTHIAZINE; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE MEMBRANE; FATTY ACID ANALYSIS; GAS CHROMATOGRAPHY; HUMAN; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM;

ADULT; ANTIPSYCHOTIC AGENTS; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; MALE; SCHIZOPHRENIA;

EID: 77956480265     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.07.001     Document Type: Article

References (37)

1. Karlsson I. Effects of different dietary levels of essential fatty acids on the fatty acid composition of ethanolamine phosphoglycerides in myelin and synaptosoma plasma membranes. J. Neurochem. 1975, 25:101-107.
2. Horrobin D.F. Schizophrenia as a prostaglandin deficiency disease. Lancet 1977, 1:936-937.
3. Yao J.K., van Kammen D.P., Welker J.A. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr. Res. 1994, 13:217-226.
4. Glen A.I., Glen E.M., Horrobin DF, Vaddadi K.S., Spellman M., Morse-Fisher N., Ellis K., Skinner F.S. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr. Res. 1994, 12:53-61.
5. Peet M., Laugharne J.D., Mellor J., Ramchand C.N. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot. Essent. Fatty Acids 1996, 55:71-75.
6. Khan M.M., Evans D.R., Gunna V., Scheffer R.E., Parikh V.V., Mahadik S.P. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr. Res. 2002, 58:1-10.
7. Assies J., Lieverse R., Vreken P., Wanders R.J., Dingemans P.M., Linszen D.H. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol. Psychiatry 2001, 49:510-522.
8. Evans D.R., Parikh V.V., Khan M.M., Coussons C., Buckley P.F., Mahadik S.P. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:393-399.
9. Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin D.F., Bennett C., Ranjekar P.K., Mahadik S.P. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol. Psychiatry 2003, 53:56-64.
10. Reddy R.D., Keshavan M.S., Yao J.K. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr. Bull. 2004, 30:901-911.
11. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC, (Text Revision). 4th ed.
12. Moser H.W., Moser A.B. Techniques in Diagnostic Human Biochemical Genetics 1991, Wiley, New York, p. 177.
13. Fenton W.S., Hibbeln J., Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol. Psychiatry 2000, 47:8-21.
14. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 1999, 56:565-570.
15. Barbour B., Szatkowski M., Ingledew N., Attwell D. Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 1989, 342:918-920.
16. Grintal B., Champeil-Potokar G., Lavialle M., Vancassel S., Breton S., Denis I. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid. Neurochem. Int. 2009, 54:535-543.
17. McNamara R.K., Ostrander M., Abplanalp W., Richtand N.M., Benoit S.C., Clegg D.J. Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:237-257.
18. Hibbeln J.R., Makino K.K., Martin C.E., Dickerson F., Boronow J., Fenton W.S. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol. Psychiatry 2003, 53:431-441.
19. Peet M. Nutrition and schizophrenia: beyond omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:417-422.
20. Rzehak P., Heinrich J., Klopp N., Schaeffer L., Hoff S., Wolfram G., Illig T., Linseisen J. Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1-FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br. J. Nutr. 2009, 101:20-26.
21. Ross B.M., Hudson C., Erlich J., Warsh J.J., Kish S.J. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Arch. Gen. Psychiatry 1997, 54:487-494.
22. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res. 2003, 121:109-122.
23. Reddy R.D., Yao J.K. Environmental factors and membrane polyunsaturated fatty acids in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:385-391.
24. Sands S.A., Reid K.J., Windsor S.L., Harris W.S. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 2005, 40:343-347.
25. Sumiyoshi T., Matsui M., Itoh H., Higuchi Y., Arai H., Takamiya C., Kurachi M. Essential polyunsaturated fatty acids and social cognition in schizophrenia. Psychiatry Res. 2008, 157:87-93.
26. Yashodhara B.M., Umakanth S., Pappachan J.M., Bhat S.K., Kamath R., Choo B.H. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad. Med. J. 2009, 85:84-90.
27. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., Lamberti S., D'Agostino R.B., Stroup T.S., Davis S., Lieberman J.A. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res. 2005, 80:45-53.
28. Peet M. The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:323-327.
29. Laugharne J.D., Mellor J.E., Peet M. Fatty acids and schizophrenia. Lipids 1996, 31:163-165.
30. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int. J. Neuropsychopharmacol. 2004, 7:1-5.
31. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., Durand G., Chalon S. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am. J. Clin. Nutr. 2002, 75:662-667.
32. McNamara R.K., Jandacek R., Rider T., Tso P., Hahn C.G., Richtand N.M., Stanford K.E. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophr. Res. 2007, 91:37-50.
33. Richardson A.J., Cyhlarova E., Ross M.A. Omega-3 and omega-6 fatty acid concentrations in red blood cell membranes relate to schizotypal traits in healthy adults. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:461-466.
34. Fernø J., Raeder M.B., Vik-Mo A.O., Skrede S., Glambek M., Tronstad K.J., Breilid H., Løvlie R., Berge R.K., Stansberg C., Steen V.M. Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?. Pharmacogenomics J. 2005, 5:298-304.
35. McNamara R.K., Able J.A., Jandacek R., Rider T., Tso P. Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis. Schizophr. Res. 2009, 107:150-157.
36. Polymeropoulos M.H., Licamele L., Volpi S., Mack K., Mitkus S.N., Carstea E.D., Getoor L., Thompson A., Lavedan C. Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia. Schizophr. Res. 2009, 108:134-142.
37. Masand PS, Roca M, Turner MS, Kane JM Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim. Care Companion J. Clin. Psychiatry 2009, 11:147-154.